Recombinant Alternative to Animal-Derived Pepsin

Application Solution

Overview

Evaluate recombinant pepsin for applications where source control, purity and batch consistency matter.

How can limitations in the source and impurity profile of animal-tissue-extracted pepsin be reduced?

Challenges

  • Animal-tissue raw materials may vary between sources
  • Controlling other proteins during extraction can be difficult
  • Activity and stability must be monitored across batches

Recommended Approach

  1. 1. Define target specifications

    Determine required activity and purity based on the substrate, pH, temperature and downstream process.

  2. 2. Select a recombinant source

    Use Pichia-expressed pepsin obtained by fermentation and purification to improve source control.

  3. 3. Run bench-scale validation

    Measure substrate conversion, stability and final-product criteria to establish dosage and reaction conditions.

Potential Benefits

  • No animal-tissue extraction
  • Controlled and stable source
  • High purity and activity
  • Easier process standardization

Related Products

Questions

Can recombinant pepsin directly replace the product used in an existing process?

Not automatically. Activity definitions, purity and formulations can differ; compare equivalent activities and validate at bench scale first.

How should the product be stored?

The current application material recommends low-temperature storage at 0–10°C; follow the label and technical documents for the delivered batch.

Discuss Your Application

Implementation conditions should be validated for your materials and process.

Contact our team →